Beam Therapeutics (BEAM) EBIT Margin Growth (1y) (2020 - 2026)
Beam Therapeutics (BEAM) EBIT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Beam Therapeutics | 2.61 Bn | 2.61 Bn | - | 125,905.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,905.00 |
| Dec 31, 2025 | 31,743.00 |
| Sep 30, 2025 | -56,120.00 |
| Jun 30, 2025 | -52,816.00 |
| Mar 31, 2025 | -19,158.00 |
| Dec 31, 2024 | -37,473.00 |
| Sep 30, 2024 | -11,669.00 |
| Jun 30, 2024 | -38,326.00 |
| Mar 31, 2024 | -99,663.00 |
| Dec 31, 2023 | 48,612.00 |
| Sep 30, 2023 | -5,181.00 |
| Jun 30, 2023 | -1,557.00 |
| Mar 31, 2023 | 49,534.00 |
| Dec 31, 2022 | -31,979.00 |
| Sep 30, 2022 | 854,844.00 |
| Jun 30, 2022 | 98.24 Mn |
| Mar 31, 2022 | 333.86 Mn |
| Dec 31, 2021 | 67.99 Mn |
| Sep 30, 2021 | 61.29 Mn |
| Jun 30, 2021 | -54.48 Mn |